Viewing Study NCT03021057


Ignite Creation Date: 2025-12-24 @ 6:42 PM
Ignite Modification Date: 2026-04-25 @ 10:47 PM
Study NCT ID: NCT03021057
Status: UNKNOWN
Last Update Posted: 2019-04-17
First Post: 2017-01-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab for T/NK-cell lymphomasNK-cell Lymphomas
Sponsor: The University of Hong Kong
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module